These findings are consistent with those of a study by Pan et al., who suggested that CRP may act as a novel pathogenic cofactor, enhancing IgG-mediated phagocytic responses, and leading to thrombocytopenia. This evidence concerns the gene CRP and Thrombocytopenia.